Suppr超能文献

人胰高血糖素和血管活性肠肽(VIP)在体外可刺激人脂肪组织释放游离脂肪酸。

Human glucagon and vasoactive intestinal polypeptide (VIP) stimulate free fatty acid release from human adipose tissue in vitro.

作者信息

Richter W O, Robl H, Schwandt P

机构信息

Medical Department II, Clinicum Grosshadern, University of Munich, FRG.

出版信息

Peptides. 1989 Mar-Apr;10(2):333-5. doi: 10.1016/0196-9781(89)90039-9.

Abstract

Glucagon, vasoactive intestinal polypeptide and secretin are strong stimulators of lipolysis in adipose tissue from laboratory animals. Yet, in human adipose tissue these data could not be confirmed under comparable experimental conditions. Using pH stat titration, an advanced in vitro test system for evaluating lipolysis, it was possible to demonstrate lipolytic activity for glucagon down to a concentration of 10(-8) mol/l. This is comparable to the minimal effective doses in rat adipose tissue and corresponds to the effect of equimolar concentrations of noradrenaline in man. Secretin with an amino acid sequence very similar to glucagon was not lipolytically active, while VIP stimulated free fatty acid release in a concentration of 10(-6) mol/l. Since the minimal effective dose of glucagon is only 30 times greater than the plasma levels a physiological significance of these finding may be suggested. The lipolytic activity of VIP seems to be only of pharmacological interest.

摘要

胰高血糖素、血管活性肠肽和促胰液素是实验动物脂肪组织中脂解作用的强刺激剂。然而,在类似的实验条件下,这些数据在人体脂肪组织中未能得到证实。使用pH计滴定法(一种用于评估脂解作用的先进体外测试系统),能够证明胰高血糖素在低至10(-8)摩尔/升的浓度下仍具有脂解活性。这与大鼠脂肪组织中的最小有效剂量相当,并且相当于人中等摩尔浓度去甲肾上腺素的作用。氨基酸序列与胰高血糖素非常相似的促胰液素没有脂解活性,而血管活性肠肽在10(-6)摩尔/升的浓度下刺激游离脂肪酸释放。由于胰高血糖素的最小有效剂量仅比血浆水平大30倍,因此可能提示这些发现具有生理意义。血管活性肠肽的脂解活性似乎仅具有药理学意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验